IMFINZI (durvalumab) is used to treat a type of lung cancer called non-small cell lung cancer. It is used when:
- Your cancer has grown within your lung and cannot be removed by surgery and,
- Your cancer has responded or stabilized after treatment with chemotherapy and radiation therapy.
IMFINZI is also used to treat adults with a type of lung cancer called extensive-stage small cell lung cancer (ES-SCLC). It is used when:
- Your cancer has spread within your lungs (or to other parts of the body) and,
- You have not previously been treated.
- For ES-SCLC, IMFINZI is given in combination with chemotherapy.
The AstraZeneca Oncology Patient Support Program
The AstraZeneca Oncology Patient Support Program is an initiative designed to provide educational and medication support for patients who have been prescribed IMFINZI. For program inquiries and more information, call 1-877-280-6208
(8 a.m. to 8 p.m. EST Monday to Friday).
A Guide to Your Treatment With IMFINZI
To provide you with key information about your treatment and to help you understand and recognize possible side effects.
Available in 13 languages
Providing Care and Support
A guide for caregivers to help them help you through the treatment process.
Cancer support resources
Explore the following association websites:
Canadian Cancer Society
Cancer Hope Network
Lung Cancer Canada